Home
Conditions
Immunoproliferative Disorders

Clinical trial condition

Immunoproliferative Disorders

Explore clinical trials studying Immunoproliferative Disorders. Study availability and eligibility vary by location and protocol.

9,958 public trials 2,018 recruiting studies

Refine in advanced search Browse all conditions

Immunoproliferative Disorders trial results

Recruiting

This is a Phase 1 Trial of ZM008, an Anti-LLT1 Antibody, Used as Single Agent Followed by Combination Treatment With Toripalimab in Patients With Advanced Solid Tumors

NCT06451497

Conditions: Biliary Tract Cancer, Biliary Tract Diseases, Biliary Tract Neoplasms, +58 more
Locations: Dana Farber Cancer Institute Boston, Massachusetts, United States

NEXT Oncology Austin, TX 78758, Texas, United States

NEXT Oncology San Antonio, Texas, United States

View Trial Details

Recruiting

Ropeginterferon in Patients w/Cutaneous T-Cell Lymphoma (CTCL)

NCT07047885

Conditions: Cutaneous T Cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
Locations: Moffitt Cancer Center Tampa, Florida, United States

View Trial Details

Recruiting

Low Dose Epcoritamab Plus GemOx in R/R DLBCL

NCT07451652

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
Locations: Hospital Universitario "Dr. José Eleuterio González" Monterrey, Nuevo León, Mexico

View Trial Details

Recruiting

Study of ISB 2001 in Relapsed/Refractory Multiple Myeloma (TRIgnite-1)

NCT05862012

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
Locations: Standford Cancer Institute Palo Alto, California, United States

Sylvester Cancer Center Miami, Florida, United States

Winship Cancer Institute Atlanta, Georgia, United States

University of Chicago Medical Center Chicago, Illinois, United States

View all 32 locations

View Trial Details

Recruiting

DZD8586 Combination Therapy in Patients With Diffuse Large B-cell Lymphoma (TAI-SHAN12)

NCT07059650

Conditions: Diffuse Large B-cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
Locations: Peking University Third Hospital Beijing, China

Hunan Cancer Hospital Changsha, China

West China Hospital of Sichuan University Chengdu, China

Guangdong Provincial People's Hospital Guangzhou, China

View all 13 locations

View Trial Details

Recruiting

Predictors of Health-Related QOL in Adults With CLL or Small Lymphocytic Lymphoma

NCT07030400

Conditions: Chronic Disease, Chronic Lymphocytic Leukemia (CLL), Disease Attributes, +15 more
Locations: Moffitt Cancer Center Tampa, Florida, United States

View Trial Details

Recruiting

Comparison of AVD + Low-Dose Nivolumab vs. PET-Adapted BEACOPP-like in Advanced cHL

NCT07234487

Conditions: Hemic and Lymphatic Diseases, Hodgkin Disease, Hodgkin Lymphoma, +7 more
Locations: A.N.Bakulev Center for cardiovascular surgery of the Russian Ministry of Health Moscow, Russia

National Medical and Surgical Center named after N.I. Pirogov Moscow, Russia

St. Petersburg State Pavlov Medical University Saint Petersburg, Russia

View Trial Details

Recruiting

Single-Arm Comprehensive Ablative Bridging Irradiation I Prior to CD19 CAR-T In High-Risk R/R LBCL

NCT06104592

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
Locations: Moffitt Cancer Center Tampa, Florida, United States

View Trial Details

Recruiting

Study of KTE-X19 in Minimal Residual Disease (MRD) Positive B-Cell Acute Lymphoblastic Leukemia (B-ALL)

NCT06144606

Conditions: Acute Lymphoblastic Leukemia, B-Cell Lymphoblastic Leukemia, Burkitt Lymphoma, +20 more
Locations: Moffitt Cancer Center Tampa, Florida, United States

View Trial Details

Recruiting

Itacitinib Pre-modulation in DLBCL Receiving CAR T Cell Therapy

NCT05757219

Conditions: Diffuse Large B Cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
Locations: Moffitt Cancer Center Tampa, Florida, United States

View Trial Details

Immunoproliferative Disorders

Immunoproliferative Disorders trial results

Related conditions